CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Authors
A Barca
A Bergamo
+71Â more
A Bergamo
A Bergamo
A Bergamo
A Vacca
B Gava
B Sanna
BE Storer
C Casarsa
CS Allardyce
D Frasca
D Pluim
Dick Pluim
E Alessio
Enzo Alessio
Erik van Werkhoven
ES Antonarakis
F Frausin
G Pintus
G Sava
G Sava
G Sava
G Sava
G Sava
G Sava
G Sava
G Sava
G Sava
G Sava
G Sava
Gianni Sava
I Kostova
I Ott
J Reedijk
J Reedijk
Jan H. M. Schellens
JM Rademaker-Lakhai
Jos H. Beijnen
L Messori
L Messori
L Morbidelli
LD Vainchtein
M Bouma
M Bouma
M Bouma
M Bouma
M Cocchietto
M Crul
M Debidda
M Galanski
M Galanski
M Magnarin
M Vadori
Matthijs Tibben
MJ Bloemink
MJ Clarke
MJ Clarke
MJ Clarke
P Therasse
P Therasse
P Therasse
Paul Baas
R Simon
RB Weiss
S Pacor
S Zorzet
SA Veltkamp
Sjaak A. Burgers
Suzanne Leijen
T Giraldi
V Brabec
V Brabec
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1007%2Fs10637-014-...
Last time updated on 04/12/2019